SEC Comment Letter 0000000000-24-006238 to Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Date: May 30, 2024 · CIK: 0000922247 · Accession: 0000000000-24-006238
AI Filing Summary & Sentiment
File numbers found in text: 333-279703
Letter
United States securities and exchange commission logo May 30, 2024 Joshua M. Fine Chief Financial Officer Cyclo Therapeutics, Inc. 6714 NW 16th Street, Suite B Gainesville, FL 32653 Re:Cyclo Therapeutics, Inc. Registration Statement on Form S-3 Filed May 24, 2024 File No. 333-279703 Dear Joshua M. Fine: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sarah Hewitt, Esq.
Show Raw Text
United States securities and exchange commission logo
May 30, 2024
Joshua M. Fine
Chief Financial Officer
Cyclo Therapeutics, Inc.
6714 NW 16th Street, Suite B
Gainesville, FL 32653
Re:Cyclo Therapeutics, Inc.
Registration Statement on Form S-3
Filed May 24, 2024
File No. 333-279703
Dear Joshua M. Fine:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Sarah Hewitt, Esq.